Supreme Court restores mifepristone access by mail

The Supreme Court restored mail ordering of mifepristone reversing a federal appeals court’s stay. The decision Monday came after makers of the pill asked for an immediate response to a ruling by a federal appeals panel in Louisiana on Friday. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing:…

Source: Endpoints News